uniQure N.V. Long-Term Debt
uniQure N.V. (QURE) had Long-Term Debt of $49.94 million as of 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2026-05-05
- 2026-03-31: Long-term Debt, Excluding Current Maturities $49.94M.
- 2025-12-31: Long-term Debt, Excluding Current Maturities $49.70M.
- 2025-09-30: Long-term Debt, Excluding Current Maturities $51.88M.
- 2025-06-30: Long-term Debt, Excluding Current Maturities $51.84M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2026-03-31 | $49.94M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $49.70M 10-Q · filed 2026-05-05 |
| 2025-09-30 | $51.88M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $51.84M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $51.59M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $51.32M 10-K · filed 2026-03-02 |
| 2024-09-30 | $51.11M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $102.51M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $102.12M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $101.75M 10-K · filed 2025-02-27 |
| 2023-09-30 | $101.43M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $101.11M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $103.25M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $102.79M 10-K · filed 2024-02-28 |
| 2022-09-30 | $102.39M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $101.89M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $101.42M 10-Q · filed 2022-05-02 |
| 2021-12-31 | $100.96M 10-K · filed 2023-02-27 |
| 2021-09-30 | $71.49M 10-Q · filed 2021-10-25 |
| 2021-06-30 | $70.78M 10-Q · filed 2021-07-26 |
| 2021-03-31 | $70.47M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $35.62M 10-K · filed 2022-02-25 |
| 2020-09-30 | $35.49M 10-Q · filed 2020-10-27 |
| 2020-06-30 | $35.37M 10-Q · filed 2020-07-30 |
| 2020-03-31 | $36.21M 10-Q · filed 2020-04-29 |
| 2019-12-31 | $36.06M 10-K · filed 2021-03-01 |
| 2019-09-30 | $35.93M 10-Q · filed 2019-10-28 |
| 2019-06-30 | $35.78M 10-Q · filed 2019-07-29 |
| 2019-03-31 | $35.63M 10-Q · filed 2019-04-29 |
| 2018-12-31 | $35.47M 10-K · filed 2020-03-02 |
| 2018-09-30 | $9.60M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $12.84M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $16.37M 10-Q · filed 2018-04-30 |
| 2017-12-31 | $19.74M 10-K · filed 2019-02-28 |
| 2017-09-30 | $14.35M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $16.15M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $17.92M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $19.63M 10-K · filed 2018-03-14 |
| 2015-12-31 | $14.63M 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |